Transcriptional suppression of human microsomal triglyceride transfer protein by hypolipidemic insulin sensitizers

Biochemical Pharmacology

Volumn 70, Issue 11, 2005, Pages 1548-1559

  Sheena, Vered ^a   Hertz, Rachel ^a   Berman, Ina ^a   Nousbeck, Janna ^a   Bar Tana, Jacob ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

HNF 4 ; Medica; MTP; PPAR ; PPAR ; Thiazolidinediones

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 3,3,14,14 TETRAMETHYLHEXADECANEDIOIC ACID; AMINO ACID DERIVATIVE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN SENSITIZING AGENT; LIGAND; LIVER PROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MUTANT PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; THREONYLALANYLALANYLALANINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONFORMATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RODENT; TATA BOX; TRANSCRIPTION INITIATION; WILD TYPE;

ANIMALS; ANTILIPEMIC AGENTS; CARRIER PROTEINS; CELL LINE; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTES; HUMANS; INSULIN; LIGANDS; MICE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PROMOTER REGIONS (GENETICS); RATS; TRANSCRIPTION, GENETIC;

EID: 27544465167     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.09.004     Document Type: Article

References (39)

1. J.R. Wetterau, M.C. Lin, and H. Jamil Microsomal triglyceride transfer protein Biochim Biophys Acta 1345 1997 136 150
2. D.A. White, A.J. Bennett, M.A. Billett, and A.M. Salter The assembly of triacylglycerol-rich lipoproteins: an essential role for the microsomal triacylglycerol transfer protein Br J Nutr 80 1998 219 229
3. J.R. Wetterau, L.P. Aggerbeck, M.E. Bouma, C. Eisenberg, A. Munck, and M. Hermeir Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia Science 258 1992 999 1001
4. D. Sharp, L. Blinderman, K.A. Combs, B. Kienzle, B. Ricci, and K. Wager-Smith Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia Nature 365 1993 65 69
5. B.H. Chang, W. Liao, L. Li, M. Nakamuta, D. Mack, and L. Chan Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein/low density lipoprotein production in a viable conditional knockout mouse J Biol Chem 274 1999 6051 6055
6. M. Raabe, M.M. Veniant, M.A. Sullivan, C.H. Zlot, J. Bjorkegren, and L.B. Nielsen Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice J Clin Invest 103 1999 1287 1298
7. U.J. Tietge, A. Bakillah, C. Maugeais, K. Tsukamoto, M. Hussain, and D.J. Rader Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B J Lipid Res 40 1999 2134 2139
8. D.L. Hagan, B. Kienzle, H. Jamil, and N. Hariharan Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specific expression and response to metabolic regulators J Biol Chem 269 1994 28737 28744
9. V. Sheena, R. Hertz, J. Nousbeck, I. Berman, J. Magenheim, and J. Bar-Tana Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4α J Lipid Res 46 2005 328 341
10. J.R. Wetterau, R.E. Gregg, T.W. Harrity, C. Arbeeny, M. Cap, and F. Connolly An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits Science 82 1998 751 754
11. C.E. Chandler, D.E. Wilder, J.L. Pettini, Y.E. Savoy, S.F. Petras, and G. Chang CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans J Lipid Res 4 2003 1887 1901
12. G.M. Ksander, R. deJesus, A. Yuan, C. Fink, M. Moskal, and E. Carlson Diaminoindanes as microsomal triglyceride transfer protein inhibitors J Med Chem 44 2001 4677 4687
13. R. Hertz, J. Magenheim, I. Berman, and J. Bar-Tana Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha Nature 392 1998 512 516
14. R. Hertz, V. Sheena, B. Kalderon, I. Berman, and J. Bar-Tana Suppression of hepatocyte nuclear factor-4alpha by acyl-CoA thioesters of hypolipidemic peroxisome proliferators Biochem Pharmacol 61 2001 1057 1062
15. B. Kalderon, N. Mayorek, L. Ben-Yaacov, and J. Bar-Tana Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo Am J Physiol Endocrinol Metab 284 2003 E795 E803
16. W.S. Harris, W.E. Connor, D.R. Illingworth, D.W. Rothrock, and D.M. Foster Effects of fish oil on VLDL triglyceride kinetics in humans J Lipid Res 31 1990 1549 1558
17. B. Staels, J. Dallongeville, J. Auwerz, K. Schoonjans, E. Leitersdorf, and J.C. Fruchart Mechanism of action of fibrates on lipid and lipoprotein metabolism Circulation 98 1998 2088 2093
18. H. Vosper, G.A. Khoudoli, T.L. Graham, and C.N. Palmer Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis Pharmacol Ther 95 2002 47 62
19. A.L. Peters Harmel, D.M. Kendall, J.B. Buse, P.J. Boyle, A. Marchetti, and H. Lau Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes Curr Med Res Opin 20 2004 215 223
20. S. Rosenblatt, B. Miskin, N.B. Glazer, M.J. Prince, K.E. Robertson Pioglitazone 026 Study Group The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus Coron Artery Dis 12 2001 413 423
21. C. Day Thiazolidinediones: a new class of antidiabetic drugs Diabet Med 16 1999 179 192
22. D.M. Jia, A. Tabaru, H. Nakamura, K.I. Fukumitsu, T. Akiyama, and M. Otsuki Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes Metabolism 49 2000 1167 1175
23. A. Carpentier, C. Taghibiglou, S.C. Van Iderstine, B. Chen, D. Rudy, and A. Aiton Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model J Biol Chem 275 2000 8416 8425
24. C. Ameen, U. Edvardsson, A. Ljungberg, L. Asp, P. Akerblad, and A. Tuneld Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver J Biol Chem 280 2005 1224 1229
25. S. Kang, N.J. Spann, T.Y. Hui, and R.A. Davis ARP-1/COUP-TF II determines hepatoma phenotype by acting as both a transcriptional repressor of microsomal triglyceride transfer protein and an inducer of CYP7A1 J Biol Chem 278 2003 30478 30486
26. R. Hertz, J. Bishara-Shieban, and J. Bar-Tana Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III J Biol Chem 270 1995 13470 13475
27. I. Issemann, and S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645 650
28. P. Tontonoz, E. Hu, J. Devine, E.G. Beale, and B.M. Spiegelman PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene Mol Cell Biol 15 1995 351 357
29. J. Bar-Tana, S. Ben-Shoshan, J. Blum, Y. Migron, R. Hertz, and J. Pill Synthesis and hypolipidemic and antidiabetogenic activities of beta,beta,beta′,beta′-tetrasubstituted, long-chain dioic acids J Med Chem 9 1989 2072 2084
30. H. Hirokane, M. Nakahara, S. Tachibana, M. Shimizu, and R. Sato Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4 Biol Chem 279 2004 45685 45692
31. B. Frenkel, J. Bishara-Shieban, and J. Bar-Tana The effect of beta,beta′-tetramethylhexadecanedioic acid (MEDICA 16) on plasma very-low-density lipoprotein metabolism in rats: role of apolipoprotein C-III Biochem J 298 1994 409 414
32. P.G. McTernan, A.L. Harte, L.A. Anderson, A. Green, S.A. Smith, and J.C. Holder Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro Diabetes 51 2002 1493 1498
33. I. Bogacka, H. Xie, G.A. Bray, and S.R. Smith The effect of pioglitazone on peroxisome proliferators-activated receptor-gamma target genes related to lipid storage in vivo Diabetes Care 27 2004 1660 1667
34. R. Hertz, and J. Bar-Tana Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans Toxicol Lett 102-103 1998 85 90
35. R.C. Cattley, J. DeLuca, C. Elcombe, P. Fenner-Crisp, B.G. Lake, and D.S. Marsman Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regul Toxicol Pharmacol 27 1998 47 60
36. J. Bar-Tana Hypolipidemia induced by PPARalpha agonists: HNF-4alpha as an alternative to PPARalpha Curr Opin Investig Drugs 5 2004 941 946
37. N.J. Woodyatt, K.G. Lambe, K.A. Myers, J.D. Tugwood, and R.A. Roberts The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs Carcinogenesis 20 1999 369 372
38. S.C. Hasmall, N.H. James, N. Macdonald, A.R. Soames, and R.A. Roberts Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression Arch Toxicol 74 2000 85 91
39. S. Brozovic, T. Nagaishi, M. Yoshida, S. Betz, A. Salas, and D. Chen CD1d function is regulated by microsomal triglyceride transfer protein Nat Med 10 2004 535 539